sorafenib has been researched along with tyramine in 2 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (tyramine) | Trials (tyramine) | Recent Studies (post-2010) (tyramine) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 5,823 | 164 | 762 |
| Protein | Taxonomy | sorafenib (IC50) | tyramine (IC50) |
|---|---|---|---|
| trace amine-associated receptor 1 | Homo sapiens (human) | 0.8818 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Akiba, J; Bae, KH; Igawa, T; Kurisawa, M; Kusano, H; Nakayama, M; Ogasawara, S; Sanada, S; Suekane, S; Sumi, A; Todoroki, K; Ueda, K; Xu, K; Yano, H | 1 |
1 review(s) available for sorafenib and tyramine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for sorafenib and tyramine
| Article | Year |
|---|---|
Growth inhibitory effect of an injectable hyaluronic acid-tyramine hydrogels incorporating human natural interferon-α and sorafenib on renal cell carcinoma cells.
Topics: Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Humans; Hyaluronic Acid; Hydrogels; Interferon-alpha; Kidney Neoplasms; Mice; Mice, Nude; Niacinamide; Phenylurea Compounds; Sorafenib; Tyramine; Xenograft Model Antitumor Assays | 2016 |